INC.

Nippon Express Europe stellt 2023 erstmals auf der LogiPharma aus

by

TOKIO, 19. Juni 2023 /PRNewswire/ — Die Nippon Express Europe GmbH, ein Konzernunternehmen von Nippon Express Holdings, Inc., stellte auf der „LogiPharma 2023″ erstmals auf der Messe aus, die von Dienstag, 25. April, bis Donnerstag, 27. April, in Lyon, Frankreich, stattfand. Logo: https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 Foto: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 Die LogiPharma 2023 ist eine der weltweit größten internationalen Fachmessen … Read more

Nippon Express Europe expone en LogiPharma 2023 por primera vez

by

TOKIO, 15 de junio de 2023 /PRNewswire/ — Nippon Express Europe GmbH, empresa del grupo NIPPON EXPRESS HOLDINGS, INC., expuso por primera vez en “LogiPharma 2023” celebrada en Lyon, Francia, del martes 25 al jueves 27 de abril. Logo: https://kyodonewsprwire.jp/img/202306136298-O1-VPF88v28 Foto: https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202306136298/_prw_PI2fl_NJKJYRjE.jpg?_ga=2.3372912.1997240702.1686531031-1438572707.1685531252 LogiPharma 2023 es una de las ferias comerciales farmacéuticas internacionales más grandes del mundo, que … Read more

Cano Health Announces Leadership Change to Advance Execution of Value Creation Plan

by

Mark Kent appointed Interim Chief Executive Officer Dr. Marlow Hernandez has agreed to step down immediately as Chief Executive Officer and remain on the Board of Directors Launches search to identify permanent CEO and to refresh the Board with additional new independent directors MIAMI, June 16, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or … Read more

Healthcare Trust Announces Preferred Stock Dividends

by

NEW YORK, June 16, 2023 /PRNewswire/ — Healthcare Trust, Inc. (Nasdaq: HTIA / HTIBP) (“HTI”) announced today that it declared quarterly dividends on its outstanding preferred stock. Specifically, HTI declared a dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) payable on July 17, … Read more

China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

by

HANGZHOU, China, June 16, 2023 /PRNewswire/ — China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company“), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on June 15, 2023, the Company has received a notification letter from Nasdaq Listing Qualifications … Read more

Evofem Biosciences Announces Financial Results for the First Quarter of 2023

by

— Increased net product revenue 37% in the first quarter of 2023 vs. prior year quarter — — Reduced operating expenses 72% — — Decreased loss from operations by 88% — — Reaffirms path to positive EBITDA — SAN DIEGO, June 16, 2023 /PRNewswire/ — Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced financial results for … Read more

Core Sound Imaging Announces Studycast & Us2.ai Partner Integration

by

Core Sound Imaging and Us2.ai finalize integration agreement. Us2.ai joins Studycast Integration Program, bringing AI-automated Echocardiography analysis and decision support tools  into clients’ imaging and reporting solution. Us2.ai is an FDA cleared app that reports on heart structure and function, with fully automated analyses of ALL heart chambers using both 2D and Doppler views, rendering a … Read more

Novavax entregará la vacuna XBB COVID monovalente según la recomendación VRBPAC de la FDA para el otoño

by

­­- Novavax está preparado para entregar la vacuna XBB COVID monovalente a base de proteínas de acuerdo con la recomendación VRBPAC de la FDA para el otoño Novavax ha desarrollado una candidata a vacuna contra la COVID XBB.1.5 monovalente a base de proteínas y se está fabricando a escala comercial con la intención de estar … Read more

Actinium Pharma to Present at the Maxim Healthcare Virtual Conference

by

NEW YORK, June 16, 2023 /PRNewswire/ — Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that the Company will participate in a fireside chat at the Maxim Healthcare Virtual Conference on Wednesday, June 21, 2023 at 12:30 PM EST. This conference will be … Read more

Azitra, Inc. Announces Pricing of Initial Public Offering

by

BRANFORD, Conn., June 15, 2023 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR) (the “Company”), a biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products, today announced the pricing of its initial public offering of 1,500,000 shares of common stock at a public offering price of $5.00 … Read more